ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 331 filers reported holding ROYALTY PHARMA PLC in Q4 2022. The put-call ratio across all filers is 0.58 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $13,330,000 | -49.0% | 331,759 | -46.6% | 5.40% | -30.4% |
| Q2 2022 | $26,139,000 | +7.9% | 621,759 | 0.0% | 7.77% | +31.1% |
| Q1 2022 | $24,224,000 | -2.2% | 621,759 | 0.0% | 5.93% | -2.0% |
| Q4 2021 | $24,777,000 | +10.3% | 621,759 | 0.0% | 6.04% | +98.4% |
| Q3 2021 | $22,470,000 | +43.6% | 621,759 | +62.9% | 3.05% | +17.5% |
| Q2 2021 | $15,648,000 | -6.0% | 381,759 | 0.0% | 2.59% | -77.3% |
| Q1 2021 | $16,652,000 | -12.8% | 381,759 | 0.0% | 11.44% | -17.2% |
| Q4 2020 | $19,107,000 | +19.0% | 381,759 | 0.0% | 13.82% | +21.0% |
| Q3 2020 | $16,061,000 | -13.3% | 381,759 | 0.0% | 11.43% | -16.3% |
| Q2 2020 | $18,534,000 | – | 381,759 | – | 13.65% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SIGULER GUFF ADVISERS, LLC | 6,761,970 | $338,436,000 | 92.73% |
| Vantage Consulting Group Inc | 21,477,282 | $1,074,938,000 | 87.53% |
| Memorial Sloan Kettering Cancer Center | 3,565,887 | $178,473,000 | 75.56% |
| HARVARD MANAGEMENT CO INC | 14,690,780 | $735,274,000 | 39.88% |
| ROBERT WOOD JOHNSON FOUNDATION | 3,958,498 | $1,981,228,000 | 21.69% |
| Brown University | 381,759 | $19,107,000 | 13.82% |
| Overbrook Management Corp | 778,511 | $38,964,000 | 9.50% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 38,714,280 | $1,937,650,000 | 4.22% |
| Lagoda Investment Management, L.P. | 96,885 | $4,849,000 | 2.61% |
| HealthCor Management, L.P. | 1,339,530 | $67,043,000 | 2.58% |